Press Release: European Medicines Agency gives second positive opinion for a paediatric-use marketing authorisation

Author (Corporate)
Series Title
Series Details 21.02.14
Publication Date 21/02/2014
Content Type

The European Medicines Agency's Committee for Medicinal Products for Human use (CHMP) in February 2014 recommended granting a paediatric-use marketing authorisation (PUMA) for Hemangiol for the treatment of proliferating infantile haemangioma. This is the second time that the CHMP has granted a positive opinion for a PUMA since their introduction by the Paediatric Regulation, which came into force in 2007.

Source Link Link to Main Source http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/02/news_detail_002030.jsp&mid=WC0b01ac058004d5c1
Related Links
ESO: Background information: Press Release: European Medicines Agency gives first positive opinion for paediatric-use marketing authorisation http://www.europeansources.info/record/press-release-european-medicines-agency-gives-first-positive-opinion-for-paediatric-use-marketing-authorisation/

Subject Categories ,
Countries / Regions